Differential effects of p38MAP kinase inhibitors on the expression of inflammation-associated genes in primary, interleukin-1β-stimulated human chondrocytes
Open Access
- 22 March 2010
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 160 (5), 1252-1262
- https://doi.org/10.1111/j.1476-5381.2010.00760.x
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Influence of p38MAPK inhibition on IL-1β-stimulated human chondrocytes: A microarray approachInternational Journal of Molecular Medicine, 2009
- The Chondroprotective Agent ITZ-1 Inhibits Interleukin-1β–Induced Matrix Metalloproteinase–13 Production and Suppresses Nitric Oxide–Induced Chondrocyte DeathJournal of Pharmacological Sciences, 2009
- Differential expression of GADD45β in normal and osteoarthritic cartilage: Potential role in homeostasis of articular chondrocytesArthritis & Rheumatism, 2008
- Guide to Receptors and Channels (GRAC), 3rd editionBritish Journal of Pharmacology, 2008
- The p38 mitogen-activated protein kinase (MAPK) pathway in rheumatoid arthritisAnnals Of The Rheumatic Diseases, 2007
- OsteoarthritisJournal of Cellular Physiology, 2007
- Inhibitory effect of p38 mitogen‐activated protein kinase inhibitors on cytokine release from human macrophagesBritish Journal of Pharmacology, 2006
- The many paths to p38 mitogen-activated protein kinase activation in the immune systemNature Reviews Immunology, 2006
- Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray ExperimentsStatistical Applications in Genetics and Molecular Biology, 2004
- Salicylate Suppresses Macrophage Nitric-oxide Synthase-2 and Cyclo-oxygenase-2 Expression by Inhibiting CCAAT/Enhancer-binding Protein-β Binding via a Common Signaling PathwayPublished by Elsevier BV ,2002